| Primary |
| Pyrexia |
38.7% |
| Headache |
9.0% |
| Nasopharyngitis |
8.1% |
| Pain |
8.1% |
| Antipyresis |
4.5% |
| Fever |
3.6% |
| Migraine |
3.6% |
| Ear Infection |
2.7% |
| Influenza |
2.7% |
| Malaise |
2.7% |
| Arthritis |
1.8% |
| Fibromyalgia |
1.8% |
| Oral Pain |
1.8% |
| Oropharyngeal Pain |
1.8% |
| Supplementation Therapy |
1.8% |
| Systemic Lupus Erythematosus |
1.8% |
| Thyroid Disorder |
1.8% |
| Toothache |
1.8% |
| Asthma |
0.9% |
| Body Temperature Increased |
0.9% |
|
| Drug Ineffective |
19.1% |
| Vomiting |
12.8% |
| Hypersensitivity |
10.6% |
| Urticaria |
9.6% |
| Rash |
8.5% |
| Throat Irritation |
5.3% |
| Hallucination |
3.2% |
| Rash Erythematous |
3.2% |
| Swelling |
3.2% |
| Therapeutic Response Unexpected |
3.2% |
| Blood Glucose Abnormal |
2.1% |
| No Adverse Event |
2.1% |
| Product Container Seal Issue |
2.1% |
| Product Quality Issue |
2.1% |
| Product Taste Abnormal |
2.1% |
| Psychomotor Hyperactivity |
2.1% |
| Retching |
2.1% |
| Screaming |
2.1% |
| Somnolence |
2.1% |
| Swelling Face |
2.1% |
|
| Secondary |
| Pyrexia |
21.5% |
| Nasopharyngitis |
10.8% |
| Arthritis |
6.5% |
| Fibromyalgia |
6.5% |
| Headache |
6.5% |
| Migraine |
6.5% |
| Systemic Lupus Erythematosus |
6.5% |
| Influenza |
5.4% |
| Body Temperature Increased |
4.3% |
| Malaise |
4.3% |
| Oral Pain |
4.3% |
| Stomatitis |
4.3% |
| Nasal Congestion |
2.2% |
| Oropharyngeal Pain |
2.2% |
| Pain |
2.2% |
| Product Used For Unknown Indication |
2.2% |
| Asthma |
1.1% |
| Procedural Pain |
1.1% |
| Rash |
1.1% |
| Supplementation Therapy |
1.1% |
|
| Drug Ineffective |
16.7% |
| Tonsillitis |
13.3% |
| Weight Decreased |
10.0% |
| Ocular Hyperaemia |
6.7% |
| Product Physical Issue |
6.7% |
| Psychomotor Hyperactivity |
6.7% |
| Rash |
6.7% |
| Urticaria |
6.7% |
| Allergy To Chemicals |
3.3% |
| Incorrect Dose Administered |
3.3% |
| Product Container Seal Issue |
3.3% |
| Product Quality Issue |
3.3% |
| Rash Generalised |
3.3% |
| Sinusitis |
3.3% |
| Throat Irritation |
3.3% |
| Throat Tightness |
3.3% |
|
| Interacting |
| Headache |
50.0% |
| Pyrexia |
50.0% |
|
|
